Concordia Pharmaceuticals Inc. S.A.R.L. v. Vitae Enim Vitae Scientific Inc.

Good Law
United States District Court, Southern District of CaliforniaSeptember 18, 20193:19-cv-01795California404 words

Opinion

Trial Court Opinion

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF SOUTH CAROLINA

GREENVILLE DIVISION

Concordia Pharmaceuticals Inc. SARL; ) Advanz Pharma Corp., formerly known as ) Concordia International Corp.; ) Concordia Pharmaceuticals (US) Inc., ) ) C.A. No. 6:19-2061-HMH-JDA Plaintiffs, ) ) vs. ) OPINION & ORDER ) Vitae Enim Vitae Scientific Inc., ) Charles Cavallino, Boris Gites, ) ) Defendants. ) This matter is before the court for review of the Report and Recommendation of United States Magistrate Judge Jacquelyn D. Austin, made in accordance with 28 U.S.C. § 636(b)(1) and Local Civil Rule 73.02 for the District of South Carolina. The magistrate judge makes only a recommendation to this court. The recommenda- tion has no presumptive weight. The responsibility to make a final determination remains with this court. See Mathews v. Weber, 423 U.S. 261, 270-71 (1976). The court is charged with making a de novo determination of those portions of the Report and Recommendation to which specific objection is made, and the court may accept, reject, or modify, in whole or in part, the recommendation of the magistrate judge or recommit the matter with…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.